Catalent, Inc. (CTLT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 54.82 |
| Open | 54.80 |
| Bid | 0.00 x 1000 |
| Ask | 59.99 x 800 |
| Day's Range | 53.96 - 54.97 |
| 52 Week Range | 31.80 - 60.20 |
| Volume | |
| Avg. Volume | 1,773,096 |
| Market Cap | 9.773B |
| Beta (5Y Monthly) | 1.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.38 |
| Earnings Date | Aug 27, 2024 - Sept 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 56.70 |
ZacksCatalent's (CTLT) Latest Partnership to Boost Clinical Trials
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ZacksCatalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
GuruFocus.comDecoding Catalent Inc (CTLT): A Strategic SWOT Insight
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.